BioCentury | May 7, 2019
Financial News

Liver cell therapy company Promethera grows Asian investor base with D round

...and final close of its series D, bringing its total to €39.7 million ($44.4 million). Itochu Corp....
BioCentury | Nov 11, 2016
Company News

Scilex, Sorrento deal

...path to near term resubmission,” with a potential 2H17 action date. The companies said that Itochu Corp....
BioCentury | Aug 16, 2016
Company News

Sorrento planning pain spinout

...response letter for the candidate. Scilex's investors include the Itochu Chemical Frontier Corp. subsidiary of Itochu Corp....
BioCentury | Apr 20, 2015
Company News

Scilex Pharmaceuticals, Itochu deal

...Itochu’s Itochu Chemical Frontier Corp. company made an undisclosed investment in neurology company Scilex. The investment...
...further details, and Itochu could not be reached. Scilex Pharmaceuticals Inc. , West Chester, Pa. Itochu Corp....
BioCentury | Apr 15, 2013
Company News

Integra LifeSciences Corp., Century Medical Inc. deal

...trials could take 24-30 months to conduct, IART said. Century Medical is a subsidiary of Itochu Corp....
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...create safer oral therapies addressing various GI disorders 2004 $55M series D, 2004 ATEL Ventures; Itochu...
BioCentury | Sep 24, 2007
Strategy

Specialty bridge to Japan

...in Japan, according to CEO Steve Engen. JapanBridge was the brainchild of MPM Capital and Itochu Corp....
...Koji Shinozaki, who co-founded JapanBridge as VP of corporate development and was formerly leader of Itochu's...
...series A1 seed money at its formation, including $1.05 million from MPM and $250,000 from Itochu...
BioCentury | May 7, 2007
Company News

Algonomics, Itochu Corp. sales and marketing update

...immunogenicity screening technology in Japan. Financial terms were not disclosed. AlgoNomics N.V. , Ghent, Belgium Itochu Corp....
BioCentury | Mar 12, 2007
Finance

Too much money

...will allow it to quickly raise cash. Returning LPs, such as GE Healthcare Financial Services, Itochu...
BioCentury | Mar 6, 2007
Financial News

MPM Capital closes $550 million fund

...including neurology company Memory (MEMY) and Australian cancer play Peplin (ASX:PEP). Investors included GE Healthcare; Itochu...
Items per page:
1 - 10 of 29
BioCentury | May 7, 2019
Financial News

Liver cell therapy company Promethera grows Asian investor base with D round

...and final close of its series D, bringing its total to €39.7 million ($44.4 million). Itochu Corp....
BioCentury | Nov 11, 2016
Company News

Scilex, Sorrento deal

...path to near term resubmission,” with a potential 2H17 action date. The companies said that Itochu Corp....
BioCentury | Aug 16, 2016
Company News

Sorrento planning pain spinout

...response letter for the candidate. Scilex's investors include the Itochu Chemical Frontier Corp. subsidiary of Itochu Corp....
BioCentury | Apr 20, 2015
Company News

Scilex Pharmaceuticals, Itochu deal

...Itochu’s Itochu Chemical Frontier Corp. company made an undisclosed investment in neurology company Scilex. The investment...
...further details, and Itochu could not be reached. Scilex Pharmaceuticals Inc. , West Chester, Pa. Itochu Corp....
BioCentury | Apr 15, 2013
Company News

Integra LifeSciences Corp., Century Medical Inc. deal

...trials could take 24-30 months to conduct, IART said. Century Medical is a subsidiary of Itochu Corp....
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...create safer oral therapies addressing various GI disorders 2004 $55M series D, 2004 ATEL Ventures; Itochu...
BioCentury | Sep 24, 2007
Strategy

Specialty bridge to Japan

...in Japan, according to CEO Steve Engen. JapanBridge was the brainchild of MPM Capital and Itochu Corp....
...Koji Shinozaki, who co-founded JapanBridge as VP of corporate development and was formerly leader of Itochu's...
...series A1 seed money at its formation, including $1.05 million from MPM and $250,000 from Itochu...
BioCentury | May 7, 2007
Company News

Algonomics, Itochu Corp. sales and marketing update

...immunogenicity screening technology in Japan. Financial terms were not disclosed. AlgoNomics N.V. , Ghent, Belgium Itochu Corp....
BioCentury | Mar 12, 2007
Finance

Too much money

...will allow it to quickly raise cash. Returning LPs, such as GE Healthcare Financial Services, Itochu...
BioCentury | Mar 6, 2007
Financial News

MPM Capital closes $550 million fund

...including neurology company Memory (MEMY) and Australian cancer play Peplin (ASX:PEP). Investors included GE Healthcare; Itochu...
Items per page:
1 - 10 of 29